Beone Medicines Insider Sold Shares Worth $44,626,424, According to a Recent SEC Filing
John Oyler, Director, Chief Executive Officer, on July 14, 2026, sold 145,861 shares in Beone Medicines (ONC) for $44,626,424. Following the Form 4 filing with the SEC, Oyler has control over a total of 51,477,911 ordinary shares of the company, with 5,445,917 shares held directly and 46,031,994 controlled indirectly. SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.